INDIANAPOLIS, May 26, 2020 /PRNewswire/ -- Emgality® (galcanezumab-gnlm) significantly improved work productivity and reduced interictal burden, defined as health and well-being between migraine ...
Emgality (galcanezumab-gnlm) significantly improved work productivity and reduced interictal burden, defined as health and well-being between migraine attacks, in an analysis of the 3-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback